Aportaciones congreso (36) Publicaciones en las que ha participado algún/a investigador/a

2009

  1. A Prolonged Therapy Improves Quality of Response, and CR Associated with Superior Outcomes, with VMP

    CLINICAL LYMPHOMA & MYELOMA

  2. Bortezomib (Velcade)/Melphalan/Prednisone (VMP) Versus Velcade/Thalidomide/Prednisone (VTP) in Elderly

    CLINICAL LYMPHOMA & MYELOMA

  3. Bortezomib and Melphalan as Part of VMP Are Associated with Similar Hematologic Toxicity to MP Alone

    CLINICAL LYMPHOMA & MYELOMA

  4. DNA DSBs Induction by Zalypsis, a Novel Marine Compound, Results in Potent Antimyeloma Activity

    CLINICAL LYMPHOMA & MYELOMA

  5. Descriptive analysis of adverse drug events registered in a computerised information system

    EJC SUPPLEMENTS

  6. Differential expression in inflammatory-related genes after preoperative chemoradiation (CRT) in normal rectal tissue compared with rectal carcinoma

    EJC SUPPLEMENTS

  7. Documento de consenso sobre estimulación cerebral profunda en la enfermedad de Parkinson

    Revista de Neurologia

  8. Erythropoiesis-Stimulating Agents: No Impact on Long-Term Outcome in MM Patients in the VISTA Trial

    CLINICAL LYMPHOMA & MYELOMA

  9. Fault identification, diagnosis and compensation of flatness errors in hard turning of tool steels

    Safety, Reliability and Risk Analysis: Theory, Methods and Applications - Proceedings of the Joint ESREL and SRA-Europe Conference

  10. Flow Cytometry Remission Is the Most Relevant Prognostic Factor for MM Patients Who Undergo ASCT

    CLINICAL LYMPHOMA & MYELOMA

  11. Improved survival in patients with refractory glioblastoma that response to Irinotecan and Bevacizumab

    EJC SUPPLEMENTS

  12. Intravenous Topotecan in patients with advanced non-small cell lung cancer pre-treated with platinum and taxanes: Results of a phase II study

    EJC SUPPLEMENTS

  13. Joining of Superalloys to Intermetallics Using Nanolayers

    1ST INTERNATIONAL CONFERENCE ON NEW MATERIALS FOR EXTREME ENVIRONMENTS

  14. Molecular staging of cT3 rectal cancer: PET-CT and immunohistochemical (IHC) profile correlations

    EJC SUPPLEMENTS

  15. New drugs and novel therapeutic principles in multiple myeloma

    EJC SUPPLEMENTS

  16. Offshore code comparison collaboration within IEA wind annex XXIII: Phase III results regarding tripod support structure modeling

    47th AIAA Aerospace Sciences Meeting including the New Horizons Forum and Aerospace Exposition

  17. Outcomes of surveillance in unselected patients with clinical stage I testicular germ cell tumors: results of a single institution series

    EJC SUPPLEMENTS

  18. Panobinostat and Bortezomib Phase I Trial in Multiple Myeloma

    CLINICAL LYMPHOMA & MYELOMA

  19. Panobinostat and Lenalidomide Combination Phase I Trial in Myeloma

    CLINICAL LYMPHOMA & MYELOMA

  20. Paradox of the Basal Ganglia Model: The Antidyskinetic Effect of Surgical Lesions in Movement Disorders

    BASAL GANGLIA IX